However, the observation made by Salama et al. [33] that displays better survival outcome for colorectal cancer patients with a high density of FOXP3 is therefore counter-intuitive and contrasts with what has been reported for other solid tumor types, including melanoma, breast, ovarian, hepatocellular, and pancreatic cancers. This evidence concerns the gene FOXP3 and familial pancreatic carcinoma.